A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
Authors
Keywords
-
Journal
CANCER
Volume 122, Issue 23, Pages 3641-3649
Publisher
Wiley
Online
2016-09-21
DOI
10.1002/cncr.30317
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Epidemic of HPV-Associated Oropharyngeal Cancer Is Here: Is It Time to Change Our Treatment Paradigms?
- (2017) Erich M. Sturgis et al. Journal of the National Comprehensive Cancer Network
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hyponatremia and perioperative complications in patients with head and neck squamous cell carcinoma
- (2015) Aaron J. Feinstein et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Targeting angiogenesis in head and neck cancer
- (2015) Maria Vassilakopoulou et al. ORAL ONCOLOGY
- Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Dalantercept, an Activin Receptor-like Kinase-1 Ligand Trap, in Patients with Advanced Cancer
- (2013) J. C. Bendell et al. CLINICAL CANCER RESEARCH
- The Role of Antiangiogenic Agents in the Treatment of Head and Neck Cancer
- (2012) N. Denaro et al. ONCOLOGY
- ALK1 as an emerging target for antiangiogenic therapy of cancer
- (2011) S. I. Cunha et al. BLOOD
- Targeting Activin Receptor-Like Kinase 1 Inhibits Angiogenesis and Tumorigenesis through a Mechanism of Action Complementary to Anti-VEGF Therapies
- (2011) Dana D. Hu-Lowe et al. CANCER RESEARCH
- Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis
- (2010) Sara I. Cunha et al. JOURNAL OF EXPERIMENTAL MEDICINE
- ALK1-Fc Inhibits Multiple Mediators of Angiogenesis and Suppresses Tumor Growth
- (2010) D. Mitchell et al. MOLECULAR CANCER THERAPEUTICS
- ALK1 signaling regulates early postnatal lymphatic vessel development
- (2009) K. Niessen et al. BLOOD
- Targeted therapies in squamous cell carcinoma of the head and neck
- (2009) Kathryn A. Gold et al. CANCER
- Phase II Study of Sunitinib in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: GORTEC 2006-01
- (2009) Jean-Pascal H. Machiels et al. JOURNAL OF CLINICAL ONCOLOGY
- Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies
- (2008) Jan. B. Vermorken et al. CANCER
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started